Automate Your Wheel Strategy on BIVI
With Tiblio's Option Bot, you can configure your own wheel strategy including BIVI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BIVI
- Rev/Share 0.0
- Book/Share 1.1789
- PB 0.9161
- Debt/Equity 0.0168
- CurrentRatio 9.3152
- ROIC -0.5399
- MktCap 20056356.0
- FreeCF/Share -0.9415
- PFCF -1.1511
- PE -1.0499
- Debt/Assets 0.0149
- DivYield 0
- ROE -1.0111
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 4
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
BioVie to Host KOL Investor Webcast to Discuss the Long COVID Treatment Landscape and its ADDRESS-LC Trial on April 10, 2025
Published: March 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
CARSON CITY, Nev., March 27, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that it will host a virtual investor event featuring key opinion leader (KOL) Lindsay McAlpine, MD, BSc (Yale University), who will join company management to discuss the unmet need and current treatment landscape for long COVID on Thursday, April 10, 2025 at 10:00 AM ET. To register, click here .
Read More
About BioVie Inc. (BIVI)
- IPO Date 2020-09-18
- Website https://bioviepharma.com
- Industry Biotechnology
- CEO Mr. Cuong Viet Do M.B.A.
- Employees 14